Current and historical daily PE Ratio for Cencora Inc (
) from 2013 to May 06 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Cencora stock (STU:ABG) PE ratio as of May 06 2024 is 24.5.
More Details
Cencora Inc (STU:ABG) PE Ratio (TTM) Chart
Cencora Inc (STU:ABG) PE Ratio (TTM) Historical Data
View and export this data going back to 2013. Start your Free Trial
Total 1260
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Cencora PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-06 | 24.5 | 2024-02-28 | 25.5 |
| 2024-05-03 | 24.5 | 2024-02-27 | 25.8 |
| 2024-05-02 | 24.9 | 2024-02-26 | 26.1 |
| 2024-04-30 | 26.4 | 2024-02-23 | 25.7 |
| 2024-04-29 | 26.4 | 2024-02-22 | 25.1 |
| 2024-04-26 | 26.5 | 2024-02-21 | 25.0 |
| 2024-04-25 | 26.5 | 2024-02-20 | 25.0 |
| 2024-04-24 | 26.3 | 2024-02-19 | 25.0 |
| 2024-04-23 | 26.3 | 2024-02-16 | 25.3 |
| 2024-04-22 | 26.3 | 2024-02-15 | 25.5 |
| 2024-04-19 | 26.6 | 2024-02-14 | 25.2 |
| 2024-04-18 | 26.4 | 2024-02-13 | 24.9 |
| 2024-04-17 | 26.4 | 2024-02-12 | 25.1 |
| 2024-04-16 | 26.6 | 2024-02-09 | 25.0 |
| 2024-04-15 | 26.1 | 2024-02-08 | 25.0 |
| 2024-04-12 | 26.1 | 2024-02-07 | 26.0 |
| 2024-04-11 | 26.1 | 2024-02-06 | 25.7 |
| 2024-04-10 | 26.3 | 2024-02-05 | 25.7 |
| 2024-04-09 | 25.9 | 2024-02-02 | 25.6 |
| 2024-04-08 | 26.3 | 2024-02-01 | 25.0 |
| 2024-04-05 | 26.3 | 2024-01-31 | 23.7 |
| 2024-04-04 | 26.6 | 2024-01-30 | 23.5 |
| 2024-04-03 | 26.5 | 2024-01-29 | 23.4 |
| 2024-04-02 | 26.7 | 2024-01-26 | 23.5 |
| 2024-03-28 | 26.4 | 2024-01-25 | 23.5 |
| 2024-03-27 | 26.5 | 2024-01-24 | 23.5 |
| 2024-03-26 | 26.4 | 2024-01-23 | 23.5 |
| 2024-03-25 | 26.3 | 2024-01-22 | 23.6 |
| 2024-03-22 | 26.4 | 2024-01-19 | 23.8 |
| 2024-03-21 | 26.1 | 2024-01-18 | 23.8 |
| 2024-03-20 | 26.3 | 2024-01-17 | 23.7 |
| 2024-03-19 | 26.2 | 2024-01-16 | 23.6 |
| 2024-03-18 | 25.9 | 2024-01-15 | 23.5 |
| 2024-03-15 | 25.6 | 2024-01-12 | 23.5 |
| 2024-03-14 | 25.0 | 2024-01-11 | 23.0 |
| 2024-03-13 | 25.1 | 2024-01-10 | 23.1 |
| 2024-03-12 | 25.5 | 2024-01-09 | 22.7 |
| 2024-03-11 | 25.3 | 2024-01-08 | 22.4 |
| 2024-03-08 | 25.5 | 2024-01-05 | 22.6 |
| 2024-03-07 | 25.6 | 2024-01-04 | 22.6 |
| 2024-03-06 | 25.4 | 2024-01-03 | 22.6 |
| 2024-03-05 | 25.4 | 2024-01-02 | 22.3 |
| 2024-03-04 | 25.6 | 2024-01-01 | 21.4 |
| 2024-03-01 | 25.9 | 2023-12-29 | 21.4 |
| 2024-02-29 | 25.3 | 2023-12-28 | 21.6 |
Cencora Inc (STU:ABG) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Cencora Inc
NAICS : 424210
SIC : 5122
ISIN : US03073E1055
Share Class Description:
STU:ABG: Ordinary SharesCompare
Compare
Traded in other countries / regions
COR.USAABC.AustriaABG.GermanyC1CO34.Brazil0HF3.UK IPO Date
2013-04-29Description
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers